Oral ciprofloxacin for the first-phase treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
Zacherle
B J
BJ
Department of Internal Medicine, Kaiser Permanente Medical Center, Honolulu, HI 96819-1495, USA.
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000737:chemistry; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000032:analysis / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology
D000890:Anti-Infective Agents; D002939:Ciprofloxacin